Arcus Biosciences (RCUS) EBIT Growth (1y) (2018 - 2026)
Arcus Biosciences (RCUS) EBIT Growth (1y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 2,150.96% |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 80.62% |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 8.65% |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 183.45% |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Arcus Biosciences | 3.57 Bn | 2.75 Bn | - | -9.84% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -9.84% |
| Dec 31, 2025 | -10.68% |
| Sep 30, 2025 | -35.24% |
| Jun 30, 2025 | 92.45% |
| Mar 31, 2025 | -662.50% |
| Dec 31, 2024 | -13.19% |
| Sep 30, 2024 | -31.25% |
| Jun 30, 2024 | -27.71% |
| Mar 31, 2024 | 81.40% |
| Dec 31, 2023 | -22.97% |
| Sep 30, 2023 | -14.29% |
| Jun 30, 2023 | -20.29% |
| Mar 31, 2023 | -28.36% |
| Dec 31, 2022 | -126.33% |
| Sep 30, 2022 | 10.41% |
| Jun 30, 2022 | 9.37% |
| Mar 31, 2022 | 7.90% |
| Dec 31, 2021 | 642.75% |
| Sep 30, 2021 | -5,134.54% |
| Jun 30, 2021 | -67.79% |